View more job listings or post a job
Theravance Biopharma Post Doctoral Fellow, Clinical Pharmacology and DMPK at Theravance Biopharma
Charles River Laboratories Senior Scientist
Nektar Therapeutics Associate Director, Non Clinical PK
University of California, Davis - CAHFS-Equine Analytical Chemistry Program CONFIRMATION TECHNICIAN (Staff Research Associate III) Requisition #03022344         
University of California, Davis - CAHFS-Equine Analytical Chemistry Program LC-MS CHEMIST (Staff Research Associate III) Requisition #03022366  
Pliant Therapeutics, Inc. Sr. Scientist, DMPK
Pliant Therapeutics, Inc. Associate Scientist/Scientist Biology
Cytokinetics Research Associate II - Senior Research Associate, DMPK
Cytokinetics Research Associate III/Senior Research Associate, HTS-Discovery Biology
Cytokinetics Research Associate III/Senior Research Associate, Discovery Biology
Post a job


Drug-Drug Interactions: Update on Risk Assessment, Clinical Evaluation, and Regulatory Requirements

Speakers: Simon Wong, Jing Wang, Jialin Mao, Kari Morrissey (Genentech); Jingjing Yu (UW); Xinning Yang (FDA); Ilaria Badagnani (Theravance Biopharma); Yurong Lai (Gilead)
Organizers: Simon Wong (Genentech), Snow Ge (Nektar)
Date: 10/16/2018
Time: 8:45-17:00
Registration fee (USD): Regular: $195; Academic: $125; For unemployed or students: $30; For vendor-show rep: $35; For major-sponsor rep (incl lunch): $0;
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (2)Catalent Pharma Solutions; WuXi AppTec
Vendor show vendors registered to date: (22)Absorption Systems; BioDuro; BioreclamationIVT; Concept Life Sciences; Corning; Cyprotex; Cytovier; Envigo; Hurel Corp; ICON PLC; Intertek; KCAS Bioanalytical & Biomarker Services; Lonza; MicroConstants; Q2 Solutions; Quintara; Quotient Sciences; Sekisui XenoTech, LLC; Seventh Wave; Simulations Plus, Inc.; SOLVO Biotechnology; WORLDWIDE CLINICAL TRIALS
Registration deadline:10/14/2018  (it will close sooner if the seating cap is reached)

About the Topic

The potential for clinical drug-drug interactions (DDIs) continues to be of key liability for the development of new medicines.  This comprehensive workshop will review techniques and strategy to assess the potential for DDI's from early discovery to clinical development. In addition, clinical case studies will be explored highlighting interactions with regulatory authorities and accompanying strategies to understand and mitigate risk and expedite compound advancement.

Specific topics to be covered: 
  • Assessment of enzyme-based DDI's (induction/inhibition) and reaction phenotyping
  • Large molecule therapeutic protein interactions with small molecules
  • Recent strategies to utilize physiologically-based modeling for risk assessment
  • Update on transporter-mediated DDI's and clinical assessment
  • Design and interpretation of clinical DDI studies
  • Clinically relevant biomarkers for the assessment of transporter-mediated DDI's
  • Update and commentary on recent (2017) FDA draft guidance for DDI's


Workshop Agenda

8:45-8:50   PBSS Welcome - Simon Wong (Genentech)

8:50-9:25   1. Introduction and DDI Basics on Inhibition, Induction and Reaction Phenotyping - Simon Wong (Genentech)

9:25–10:00   2. Assessment of Therapeutic Protein Drug-Drug Interactions with Small Molecules - Jing Wang (Genentech)

10:00-10:10   Major Sponsor Presentation - TBD

10:10-10:35   Break & Vendor Show  

10:35-11:20   3. Physiologically-Based Modelling and DDI Risk Assessment - Jialin Mao (Genentech)

11:20–12:00   4. Design and Interpretation of Clinical DDI Studies - Kari Morrissey  (Genentech)

12:00-1:00   Lunch   

1:00–1:45   5. What Can Be Learned from Recent NDAs? Key Findings on Drug Interactions for Drugs Approved by the FDA - Jingjing Yu (University of Washington)

1:45–2:30   6. Update of DDI Draft Guidance - Xinning Yang (FDA)

2:30-2:40   Major Sponsor Presentation - TBD

2:40-3:00   Break & Vendor Show  

3:00-3:45   7. Transporter-mediated DDIs – What’s new in 2017 FDA draft guidance and industry application and risk assessment - Ilaria Badagnani (Theravance Biopharma)

4:00-4:45   8. Clinical Biomarkers for Transporter Mediated DDI - Yurong Lai (Gilead)

4:45-5:15   Panel Discussion - All

2018-11-01, cGMP Compliance for Quality Control and Laboratory Operations
2018-11-16, Hybrid LC-MS for Protein therapeutics and biomarkers: Recent developments in characterization and quantification
2018-12-04, Challenges in Peptide Drug Discovery & Development: Biology, Chemistry, PK, Delivery, Regulatory and Beyond
2019-02-07, Covalent Inhibitor Drug Discovery & Development: Biology, Chemistry, PK, Safety and Case Studies (Jointly with Bay Area PKPD Network)
2019-03-07, Promising therapeutic approaches and transnational medicine from SPARK: an academic-industry collaboration to advance novel therapeutics (A Joint Symposium by PBSS and Stanford SPARK Program)
2019-03-11, Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
©Pharmaceutical & BioScience Society, International; Last Modified: 10/22/2018; Visited: 44; Admin Logon
Ads (in random order)
Submit a Text Ad
($200 for 2 months)

UC Davis UC Davis Liquid Chromatography/Mass Spectrometry and Confirmation Supervisor Apply Online: UC Davis i
Reaction Biology Corporation (RBC) RBC provides kinase & epigenetic assays and proteins for early-stage programs. Contact:
Simulations Plus ADMET Predictor™ 9 - ADMET property estimation, HTPK Simulation, SAR elucidation, and QSAR model building software.
Charles River 2nd Annual Viral Summit The 2-day summit unites industry experts in an interactive setting to share updates and discuss trends in viral safety and viral clearance.
Pharm-Olam International Pharm-Olam is a midsize CRO offering a wide range of Phase I-IV comprehensive, clinical research services to the pharma, biotech & device industries.
PHARMA INVENTOR Vancouver based Canadian Custom Synthesis Services Company, Offers Inventive & Cost-Effective Chemical Synthesis Services to Life Sciences Industries.
Clinverse Inc. A global technology company solely focused on automating the financial management of clinical trials.
Pacific BioLabs Offers toxicology,microbiology,analytical and bioanalytical services with a combination of technical expertise & rigorous quality systems.
Sirius Analytical Services and Automated Instruments for pKa, log P/D, solubility, dissolution. New Scissor instrument for sub-cutaneous injection site simulation.
Avecia Pharma Services Nitto Avecia Pharma provides GMP contract development and parenteral manufacturing services to the pharma/biotech industries. Visit our Irvine labs!
Protein Characterization Seminar hosted by Charles River Join us in San Diego on September 15, 2017 to discuss the analytical methods used to detect process residuals and determine biosimilarity.
Origin Bioanalytical Laboratory A contract research organization for bioanalytical LC-MS/MS analysis specializing in ocular tissues/fluids located Rancho Cordova, CA
S-Matrix Fusion QbD® Software – Analytical Method Development & Validation, Formulation & Process R&D. Works with ChemStation, Chromeleon, and Empower.
INTERTEK PHARMACEUTICAL SERVICES Intertek, a bioanalytical CRO (drugs, biologics, proteins, ADCs, biosimilar, generics, peptide, biomarker, immunogenicity, ADA, Nab) in San Diego CA
MicroConstants MicroConstants is a GLP-compliant Contract Research Organization focused on performing regulated bioanalysis, drug metabolism and PK analysis.
Pharmaron Our Vision: To become the world-leading small-molecule life science R&D service company, supporting our partners from discovery to commercialization
Solid Form Solutions Ltd Solid Form Solutions Ltd CRO providing Solid State Crystallization and Analytical Testing Services to the pharma/biotech industries.
Simulations Plus From the developers of GastroPlus™ comes PKPlus™. NCA & compartmental PK modeling for regulatory submissions. True "PlugNPlay" PK.
Nuventra Pharma Sciences With a background in clinical pharmacology and PK/PD, Nuventra enables our clients to make better strategic decisions.
Simulations Plus GastroPlus™ PBPK modeling workshops scheduled around the globe to train scientists on the new guidance documents from the FDA and EMA. Register today!
BIOTECH WEEK BOSTON - Sept. 4-7 Join us at Biotech Week Boston - Where Big Science and Bright Minds Meet. Sept. 4-7, 2018 at Hynes Convention Center.
Nektar Therapeutics Sr. Scientist - Bioanalytical Contributes to the development, validation, and implementation of ligand-binding assays. PhD and 5 years exp.
Simulations Plus From sketching chemical structures, all the way through regulatory filings, Simulations Plus consulting experts can help. Over 20 years of experience!
Zef Scientific California’s premier multi-vendor LC-MS/MS engineering firm with highest level of services & rapid onsite response on all major brands & models.
Hypha Discovery Specialists in provision of drug metabolites at mg-g scale, including CYP/Non-CYP metabolites and conjugates such as glucuronides/sulfates.
Submit a Text Ad